$GSTC IMO the Best statement made for this clinical trial going forward> "“We were impressed with the clinical results obtained in Italy for treatment of multiple sclerosis patients using Project Amethyst,” said Stanley Satz, PhD, AIP’s chairman and chief science officer.
“These results provide a good foundation for establishing more comprehensive clinical trials with AIP’s partners,” Satz said, adding, “We are thrilled to advance the opportunities for Project Amethyst.”